Testing effectiveness (Phase 2)UnknownNCT04296786
What this trial is testing
Sintilimab Plus Chidamide in the Treatment of Relapsed and Refractory Cutaneous T-cell Lymphoma: a Multicenter Phase II Study
Who this might be right for
Cutaneous T-cell Lymphoma
Peking Union Medical College Hospital 52